RPRX

NASDAQ · Pharmaceuticals

Royalty Pharma Plc- Cl A

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$50.79

+0.59 (+1.18%)

As of May 9, 1:03 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target -28.6% upside

Low Target $26.65

Average Target $36.26

High Target $40.53

Current Price $50.79

Current
$50.79

Target
$36.26

$26.65 $36.26 avg $40.53

Scenario Analysis

Bear Case

$26.65

-47.5%

Low target

Base Case

$36.26

-28.6%

Avg target

Bull Case

$40.53

+-20.2%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$51.65

-1.7% from high

52-Week Low

$32.15

+58.0% from low

50-Day SMA

$40.77

+24.6% vs SMA

200-Day SMA

$37.28

+36.2% vs SMA

RSI (14)

85.1

Overbought

Target vs 52W High

$36.26

-29.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	69%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	35	43%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%